Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 25, 2023
Abstract
Background:
Even
though
the
COVID-19
vaccination
roll-out
in
general
can
be
considered
as
one
of
most
successful
public
health
campaigns
history
medicine,
hesitancy
has
remained
an
issue
concern
throughout
world.
We
add
to
a
deeper
understanding
by
identifying
what
drives
primary
and
booster
uptake,
well
adherence
simple
preventive
measures
such
physical
distancing
investigating
role
Dark
Triad
personality
traits,
i.e.
Machiavellianism,
narcissism,
psychopathy.
Methods:
investigate
data
from
Germany
United
Kingdom
European
Covid
Survey
which
was
collected
23
December
2021
10
January
2022.
Logit
regressions
random
effects
were
performed
study
effect
dark
traits
on
COVID-19-related
prevention.
Results:
show
that
have
substantial
impact
prevention
efforts,
vaccinations
uptake
against
COVID-19.
Specifically,
individuals
scoring
high
psychopathy
significantly
less
likely
received
immunization.
The
difference
amounts
10.5%-points.
High
narcissistic
imply
substantially
higher
likelihood
(15.3%-points)
refuse
shots
after
having
vaccinations.
Therefore,
may
constitute
special
case
demand
for
vaccines.
In
addition,
with
psychopathic
tendencies
engage
other
behavior,
while
scores
narcissism
lead
reported
measures.
Conclusions:
Our
findings
highlight
crucial
plays
pandemic
related
Policymakers,
professionals,
those
charge
messaging
take
these
factors
into
account
when
devising
communication
strategies
improve
behaviors.
Future
pandemics
crises
would
benefit
targeted,
nuanced
approaches
promote
greater
health.
The Journals of Gerontology Series A,
Год журнала:
2024,
Номер
79(4)
Опубликована: Янв. 10, 2024
Abstract
Background
We
assessed
the
incidence,
quality
of
in-hospital
care,
and
mortality
for
hip
fracture
(HF)
patients
in
Denmark
before
during
coronavirus
disease
(COVID)
pandemic.
Methods
obtained
data
from
Danish
registries
COVID
period
(March
11,
2020
to
January
27,
2021,
overall
5
periods)
compared
it
a
pre-COVID
13,
2019
March
10,
2020).
calculated
proportion
(%)
that
have
fulfilled
all
relevant
indicators
(a
composite
score
100%)
adjusted
hazard
ratios
(HR)
with
95%
confidence
interval
(CI)
30-day
mortality.
Results
The
incidence
HF
was
5.7
per
1
000
person-years
both
periods.
About
35%
had
100%
28%
(proportion
ratio
1.23
[95%
CI:
1.17–1.30]).
Fulfillment
individual
similar
or
higher
period.
9.5%
period,
10.8%
(HR
1.15
1.02–1.30]).
HRs
varied
1.07
(95%
0.89–1.29)
1.31
1.06–1.62)
In-hospital
4%
versus
4.4%
Conclusions
remained
unchanged.
care
Unfortunately,
also
higher,
highlighting
importance
recognizing
diversity
social
networks,
home
support,
digital
health
intervention
after
discharge
outcome
patients.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 25, 2024
Abstract
We
propose
a
decision
support
tool,
based
on
Mixed
Integer
Programming,
to
help
with
the
planning
of
national
vaccination
campaigns,
and
test
it
data
scenarios
obtained
from
publicly
available
information
about
Irish
COVID-19
program.
show
that
large
variety
constraints
can
be
included
in
as
well
combinations
different
objective
functions
for
stakeholders.
The
tests
multi-period/multi-vaccine
problem
effectively
solved
by
given
model,
while
allowing
consider
impact
potential
changes
input
data.
also
present
number
specific
visualizations
user
understand
plan
created
application.
Vaccines,
Год журнала:
2024,
Номер
12(10), С. 1090 - 1090
Опубликована: Сен. 24, 2024
Background/Objectives.
Many
vaccines
have
been
developed
in
recent
decades,
and
many
more
will
be
available
the
future.
When
new
safe
effective
are
available,
decision-makers
must
extensively
assess
them
before
including
national
immunization
plan
issuing
recommendations.
The
Health
Technology
Assessment
(HTA)
could
an
objective,
transparent,
comprehensive
approach
to
guiding
decision-making
process
for
use
of
vaccines.
Objectives
Methods.
aim
this
study
was
review
indications
HTA
contained
Italian
institutional
documents
on
vaccination,
namely
National
Immunization
Plans
(NIPs)
full
reports
vaccines,
assessing
their
availability
at
time
recommendations’
introductions.
Results.
has
recognised
as
eligible
deciding
upon
introduction
through
NIPs
2012–2014
2017–2019,
last
NIP,
2023–2025,
highlights
lack
funding
dedicated
production
independent
that
can
used
In
2007–2023,
twenty
were
published
Italy:
eight
influenza
five
Human
Papilloma
Virus
(HPV),
three
each
meningococcal
pneumococcal
one
rotavirus
vaccine.
applied
with
different
purposes,
evaluation
or
re-assessment,
but
it
not
always
timely
respect
both
marketing
authorisation
recommendations
use.
Conclusions.
As
considered
best
tool
disentangle
overall
value
would
desirable
provide
evidence
efficient
resource
This
calls
action
improve
transfer
results
decision-makers,
try
fill
gap
between
research
decision
foster
evidence-based
Vaccines,
Год журнала:
2024,
Номер
12(10), С. 1093 - 1093
Опубликована: Сен. 25, 2024
:
COVID-19
vaccines
were
rapidly
developed
and
deployed
on
a
large
scale
during
global
crisis.
A
range
of
deployment
strategies
used
globally
to
maximize
vaccine
uptake.
In
this
scoping
review,
we
identify
analyze
the
main
healthcare
system
policy
factors
that
guided
influenced
vaccination
uptake
globally.
Journal of Vaccines and Immunology,
Год журнала:
2023,
Номер
9(1), С. 030 - 036
Опубликована: Авг. 19, 2023
Background:
The
Coronavirus
disease-2019
(COVID-19)
pandemic
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
significant
global
health
threat.
In
this
study,
we
investigated
antibody
response
in
five-time
intervals
following
COVISHEILD
first,
second,
and
booster
doses
vaccination
previously
infected
non-infected
individuals.
Methods:
study
was
cross-sectional
prospective
that
took
place
at
Bangladesh
Institute
of
Tropical
Infectious
Diseases
(BITID),
Fouzderhat,
Chittagong,
46
individuals
who
received
vaccine
from
February
2021
to
January
2022.
Blood
samples
were
collected
recipients
five
different
time
points
(Baseline:
Day
0
before
1st
dose,
3
weeks,
months
(before
2nd
dose),
6
months,
1
year
after
dose)
measure
levels
S-RDB
IgG
antibodies
using
EUROIMMUN
Anti-S-Rose
Disease
Bioinfection
assay
test
kits
(Lübeck,
Germany).
Results:
reveals
with
prior
SARS-CoV-2
infection
showed
increase
receiving
first
reaching
145.51
units
weeks
post-vaccination.
This
remained
stable
117.6
slightly
declined
103.26
indicating
sustained
immune
response.
For
individuals,
induced
strong
response,
159.62
increasing
150
then
declining
87.84
months.
Despite
decline,
notably
higher
than
pre-vaccination
baseline
units,
development
durable
vaccination.
<40
years
age
group,
substantial
boost
198.61
122.22
73.7
followed
rise
263.85
year.
Conclusion:
Our
findings
highlight
tailoring
approaches
based
on
gender
differences
considering
both
will
aid
optimizing
responses
combatting
COVID-19
epidemic
effectively.
Vaccines,
Год журнала:
2023,
Номер
11(12), С. 1859 - 1859
Опубликована: Дек. 16, 2023
Several
studies
reported
post-SARS-CoV-2-vaccination
(PV)
symptoms.
Even
people
with
multiple
sclerosis
(PwMS)
have
concerns
about
disease
activity
following
the
SARS-CoV-2
vaccination.
We
aimed
to
determine
proportion
of
PwMS
PV
relapses,
annualized
relapse
rate
(ARR),
time
from
vaccination
subsequent
and
identify
sociodemographic/clinical
risk
factors
for
relapses.
were
surveyed
several
times
at
baseline
four
follow-ups
as
part
a
longitudinal
observational
study
regarding
safety
tolerability
The
inclusion
criteria
this
analysis
age
≥18
years,
≥1
vaccination,
≥1-year
observation
period
since
initial
Of
2466
PwMS,
13.8%
relapses
(mostly
after
second
[N
=
147]
or
booster
145])
median
8.0
(first/third
quantile:
3.55/18.1)
weeks
PV,
shortest
(3.95
weeks).
ARR
was
0.153
(95%
confidence
interval:
0.138-0.168),
1.2
years.
Risk
younger
age,
female
gender,
moderate-severe
disability
levels,
concurrent
autoimmune
diseases,
relapsing-remitting
MS
courses,
no
DMT,
within
year
prior
first
Patients'
health
conditions
before/during
may
play
more
important
role
in
occurrence
than
per
se.
Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 22, 2023
Abstract
Policy
analysis
is
a
multi-disciplinary
approach
to
public
and
social
policy
that
aims
explain
the
interaction
between
institutions,
ideas,
interests
in
policymaking
process.
It
useful
prospectively
plan
for
future
retrospectively
understand
past
failures
or
identify
good
practices.
However,
current
methods
of
systematically
mapping
health
are
lacking
qualitative
research
field.
In
this
article,
we
outline
novel
methodological
toolkit
allows
systematic
reviewing
developments
cross-sectionally
longitudinally
through
modular
approach:
(1)
develop
comprehensive
search
strategy
databases;
(2)
review
extract
relevant
policies
legislation
directly
from
original
sources;
(3)
multi-layered
scientific
(4)
merge
academic
publications
according
eligibility
criteria;
(5)
acquire
further
information
searching
reference
lists
included
articles;
(6)
three
searches
into
one
single
data
repository
analysis.
Our
gives
point-by-point
description
how
design,
perform,
report
reproduceable
as
well
can
be
analysed
lead
prospective
action
points.
